Cargando…

Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation

OBJECTIVE: Anti Mullerian hormone (AMH) is gaining place as ovarian marker, chiefly in infertility assistance. We explored its correlation with oocytes retrieval after long GnRH agonist protocol for stimulation, in younger and older infertile population. METHODS: This retrospective analysis compiled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamil, Zehra, Fatima, Syeda Sadia, Rehman, Rehana, Alam, Faiza, Arif, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017108/ https://www.ncbi.nlm.nih.gov/pubmed/27648045 http://dx.doi.org/10.12669/pjms.324.10267

Ejemplares similares

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015)

What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
por: Knez, Jure, et al.
Publicado: (2015)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments
por: Anckaert, Ellen, et al.
Publicado: (2012)

Ovarian stimulation with GnRH analogues
por: Montenegro, Ivan S., et al.
Publicado: (2014)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Ovarian Hyper-Response to Administration of an GnRH-Agonist Without Gonadotropins
por: Park, Hyun Tae, et al.
Publicado: (2011)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

Cumulus Cells Gene Expression Profiling in Terms of Oocyte Maturity in Controlled Ovarian Hyperstimulation Using GnRH Agonist or GnRH Antagonist
por: Devjak, Rok, et al.
Publicado: (2012)

Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review
por: Kuan, Kevin K.W., et al.
Publicado: (2023)

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer
por: Gründker, Carsten, et al.
Publicado: (2003)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
por: Gründker, Carsten, et al.
Publicado: (2021)

Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers
por: Jamil, Zehra, et al.
Publicado: (2016)

Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection
por: Boza, Aysen, et al.
Publicado: (2016)

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study
por: Huang, Ming-Chao, et al.
Publicado: (2018)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)

Comparison of long GnRH agonist versus GnRH antagonist protocol in poor responders
por: Şahin, Sadık, et al.
Publicado: (2014)

Evaluation of protective effects of GnRH agonist or antagonist on ovarian reserve with anti-Müllerian hormone and histological analysis in a rat model using cisplatin
por: Tas, Mustafa, et al.
Publicado: (2019)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

GnRH Agonist Therapy in a Patient with Recurrent Ovarian Granulosa Cell Tumors
por: Kim, Hyun Jung, et al.
Publicado: (2009)

Weaned Sows with Small Ovarian Follicles Respond Poorly to the GnRH Agonist Buserelin
por: Lopes, Tania P., et al.
Publicado: (2020)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
por: Eftekhar, Maryam, et al.
Publicado: (2013)

Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
por: Jamil, Zehra, et al.
Publicado: (2016)

Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis
por: Xiao, Jin-song, et al.
Publicado: (2014)

Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis
por: Wang, Ruolin, et al.
Publicado: (2017)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment
por: Nam, Hyo-Kyoung, et al.
Publicado: (2017)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017)

A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
por: Gordts, S., et al.
Publicado: (2012)

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger and freeze-all strategy in GnRH antagonist protocol; case report and literature review
por: Hajizadeh, Nazanin, et al.
Publicado: (2023)

GnRH Agonist Therapy to Protect Ovarian Function in Young Korean Breast Cancer Patients
por: Park, Hyun Jung, et al.
Publicado: (2010)

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization
por: Jing, Miaomiao, et al.
Publicado: (2020)

Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023)

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
por: Cimino, Irene, et al.
Publicado: (2016)

Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes
por: Pinto, Fátima, et al.
Publicado: (2009)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
por: Yang, Wen-Jui, et al.
Publicado: (2009)

Use of GnRH Agonist in Dogs Affected with Leishmaniosis
por: Pugliese, Michela, et al.
Publicado: (2021)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
por: Liu, Shan, et al.
Publicado: (2021)

Effects of GnRH agonists on the expression of developmental follicular anti-mullerian hormone in varying follicular stages in cyclic mice in vivo
por: HUANG, JILIANG, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6r1h5i2e17i4j4r7mr5945r1i3